UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

Journal of the American College of Cardiology, 2015-05, Vol.65 (20), p.2211-2221

2015

Link zum Volltext

Verfügbarkeit prüfen

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents

The American journal of cardiology, 2015-09, Vol.116 (5), p.686-693

2015

Link zum Volltext

Verfügbarkeit prüfen

The EVEREST II Trial: Design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation

The American heart journal, 2010-07, Vol.160 (1), p.23-29

2010

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

The American heart journal, 2010-12, Vol.160 (6), p.1035-1041.e1

2010

Link zum Volltext

Verfügbarkeit prüfen

Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents

The American heart journal, 2015-02, Vol.169 (2), p.222-233.e5

2015

Link zum Volltext

Verfügbarkeit prüfen

Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents

JACC. Cardiovascular interventions, 2016-01, Vol.9 (2), p.138-147

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)

The American journal of cardiology, 2015-06, Vol.115 (12), p.1678-1684

2015

Link zum Volltext

Verfügbarkeit prüfen

Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients with ST-Segment Elevation Myocardial Infarction in the United States

JACC. Cardiovascular interventions, 2016-12, Vol.9 (23), p.2376-2386

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Recurrent Events in Patients With Cryptogenic Stroke and Patent Foramen Ovale Within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) Trial

JACC. Cardiovascular interventions, 2014-08, Vol.7 (8), p.913-920

2014

Link zum Volltext

Verfügbarkeit prüfen

Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?

The American heart journal, 2014-07, Vol.168 (1), p.103-109

2014

Link zum Volltext

Verfügbarkeit prüfen

The “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent

JACC. Cardiovascular interventions, 2013-04, Vol.6 (4), p.325-333

2013

Link zum Volltext

Verfügbarkeit prüfen

Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting Stent

The American journal of cardiology, 2016-10, Vol.118 (8), p.1178-1186

2016

Link zum Volltext

Verfügbarkeit prüfen

Final 5-Year Outcomes From the Endeavor Zotarolimus-Eluting Stent Clinical Trial Program

JACC. Cardiovascular interventions, 2013-05, Vol.6 (5), p.504-512

2013

Link zum Volltext

Verfügbarkeit prüfen

Distribution of Coronary Artery Disease and Relation to Mortality in Asymptomatic Hemodialysis Patients

American journal of kidney diseases, 2007-03, Vol.49 (3), p.409-416

2007

Link zum Volltext

Verfügbarkeit prüfen

The PROXIMAL Trial: Proximal Protection During Saphenous Vein Graft Intervention Using the Proxis Embolic Protection System

Journal of the American College of Cardiology, 2007-10, Vol.50 (15), p.1442-1449

2007

Link zum Volltext

Verfügbarkeit prüfen

Reply

Journal of the American College of Cardiology, 2015, Vol.66 (18), p.2056-2056

2015

Link zum Volltext

Verfügbarkeit prüfen

Reply

Journal of the American College of Cardiology, 2015, Vol.66 (10), p.1204-1205

2015

Link zum Volltext

Verfügbarkeit prüfen

One-Year Outcomes of Percutaneous Coronary Intervention With the 38-mm Resolute Zotarolimus-Eluting Stent

The American journal of cardiology, 2013-11, Vol.112 (9), p.1335-1341

2013

Link zum Volltext

Verfügbarkeit prüfen

An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial

Journal of the American Society of Hypertension, 2015-10, Vol.9 (10), p.769

2015

Link zum Volltext

Verfügbarkeit prüfen

Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease

JACC. Cardiovascular interventions, 2017-05, Vol.10 (9), p.942-954

2017

Link zum Volltext

Verfügbarkeit prüfen

Cangrelor Use Since FDA Approval

Journal of the American College of Cardiology, 2017-01, Vol.69 (4), p.463-464

2017

Link zum Volltext

Verfügbarkeit prüfen

5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent

JACC. Cardiovascular interventions, 2017-02, Vol.10 (3), p.247-254

2017

Link zum Volltext

Verfügbarkeit prüfen

Dual Antiplatelet Therapy Duration and Clinical Outcomes Following Treatment With Zotarolimus-Eluting Stents

JACC. Cardiovascular interventions, 2011-10, Vol.4 (10), p.1119-1128

2011

Link zum Volltext

Verfügbarkeit prüfen

Impact of Moderate Renal Insufficiency on Restenosis and Adverse Clinical Events After Sirolimus -Eluting and Bare Metal Stent Implantation (from the SIRIUS Trials)

The American journal of cardiology, 2010-11, Vol.106 (10), p.1436-1442

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Cardiovascular
(56)
Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Cardiovascular System & Cardiology
(31)
Humans
(31)
Cardiac & Cardiovascular Systems
(29)
Male
(26)
Female
(25)
Middle Aged
(24)
Treatment Outcome
(23)
Drug-Eluting Stents
(17)
Heart Attacks
(17)
Stents
(17)
Aged
(16)
Time Factors
(15)
Internal Medicine
(14)
Cardiology And Cardiovascular Medicine
(12)
Prospective Studies
(12)
Biological And Medical Sciences
(11)
Cardiology. Vascular System
(11)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier ScienceDirect Journals Complete
(58)
IngentaConnect Journals
(56)
Ingenta
(56)
EZB Electronic Journals Library
(37)
MEDLINE
(31)
Journals@Ovid Ovid Full Text
(18)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(17)
Publisher or Other Site
(10)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents

The EVEREST II Trial: Design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation

Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents

Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents

Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)

Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients with ST-Segment Elevation Myocardial Infarction in the United States

Predictors of Recurrent Events in Patients With Cryptogenic Stroke and Patent Foramen Ovale Within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) Trial

Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?

The “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent

Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting Stent

Final 5-Year Outcomes From the Endeavor Zotarolimus-Eluting Stent Clinical Trial Program

Distribution of Coronary Artery Disease and Relation to Mortality in Asymptomatic Hemodialysis Patients

The PROXIMAL Trial: Proximal Protection During Saphenous Vein Graft Intervention Using the Proxis Embolic Protection System

Reply

Reply

One-Year Outcomes of Percutaneous Coronary Intervention With the 38-mm Resolute Zotarolimus-Eluting Stent

An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial

Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease

Cangrelor Use Since FDA Approval

5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent

Dual Antiplatelet Therapy Duration and Clinical Outcomes Following Treatment With Zotarolimus-Eluting Stents

Impact of Moderate Renal Insufficiency on Restenosis and Adverse Clinical Events After Sirolimus -Eluting and Bare Metal Stent Implantation (from the SIRIUS Trials)

Suchergebnisse filtern